Nadia Peragine

8PUBLICATIONS
37CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCardiovascular medicine and haematology not elsewhere classifiedPredictive and prognostic markersHaematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 22, 2026
Immunomodulatory effect of dasatinib plus blinatumomab versus ponatinib plus blinatumomab in newly diagnosed Ph+ acute lymphoblastic leukemia.

Michela Ansuinelli, Nadia Peragine, Maria Stefania De Propris

|May 13, 2023
Long-Term Host Immune Modulation Following Tisagenlecleucel Administration in Patients with Diffuse Large B-Cell Lymphoma and B-Lineage Acute Lymphoblastic Leukemia.

Anna Guarini, Giulia Radice, Nadia Peragine

|May 02, 2022
Hairy cell leukaemia with low CD103 expression: A rare but important diagnostic pitfall.

Maria Stefania De Propris, Paolo Musiu, Stefania Intoppa

|Sep 29, 2021
Complex karyotype in unfit patients with CLL treated with ibrutinib and rituximab: the GIMEMA LLC1114 phase 2 study.

Gian Matteo Rigolin, Ilaria Del Giudice, Antonella Bardi

|Jul 23, 2021
Host immune system modulation in Ph+ acute lymphoblastic leukemia patients treated with dasatinib and blinatumomab.

Maria Cristina Puzzolo, Giulia Radice, Nadia Peragine

|May 14, 2021
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases.

Fortunato Morabito, Giovanni Del Poeta, Francesca Romana Mauro

Pageof 2

Frequent Collaborators

2 joint publications

Gianluigi Reda

2 joint publications

Luca Laurenti

2 joint publications

Yair Herishanu

2 joint publications

Marzia Varettoni